BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32328342)

  • 1. Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses.
    Liu Z; Zhang R; Sun Z; Yao J; Yao P; Chen X; Wang X; Gao M; Wan J; Du Y; Zhao S
    PeerJ; 2020; 8():e8670. PubMed ID: 32328342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Key Pathogenic Genes and Small Molecule Compounds for PNET.
    Zhou Q; Liu H; Liu J; Liu Z; Xu C; Zhang H; Xin C
    J Pediatr Hematol Oncol; 2023 Mar; 45(2):e180-e187. PubMed ID: 36524840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes and small-molecule compounds related to intracerebral hemorrhage with bioinformatics analysis.
    Liu Z; Zhang R; Chen X; Yao P; Yan T; Liu W; Yao J; Sokhatskii A; Gareev I; Zhao S
    PeerJ; 2019; 7():e7782. PubMed ID: 31667013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
    Xing X; Xia Q; Gong B; Shen Z; Zhang Y
    Front Genet; 2022; 13():855557. PubMed ID: 35368701
    [No Abstract]   [Full Text] [Related]  

  • 6. Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis.
    Yang B; Dai JX; Pan YB; Ma YB; Chu SH
    Oncol Lett; 2019 Jul; 18(1):433-441. PubMed ID: 31289514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis.
    Hou YP; Diao TT; Xu ZH; Mao XY; Wang C; Li B
    Front Mol Biosci; 2021; 8():691966. PubMed ID: 35059432
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of PBK as a hub gene and potential therapeutic target for medulloblastoma.
    Deng Y; Wen H; Yang H; Zhu Z; Huang Q; Bi Y; Wang P; Zhou M; Guan J; Zhang W; Li M
    Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35593307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
    Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
    J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
    Zhang X; Yang L; Chen W; Kong M
    Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
    Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
    PeerJ; 2019; 7():e7408. PubMed ID: 31392101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis.
    Liao Y; Yin G; Wang X; Zhong P; Fan X; Huang C
    Oncol Lett; 2019 Oct; 18(4):3723-3733. PubMed ID: 31516585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hub Genes in Pediatric Medulloblastoma by Multiple-Microarray Analysis.
    Huang P; Guo YD; Zhang HW
    J Mol Neurosci; 2020 Apr; 70(4):522-531. PubMed ID: 31820345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
    Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
    Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics identification of key candidate genes and pathways associated with systemic lupus erythematosus.
    Yang F; Zhai Z; Luo X; Luo G; Zhuang L; Zhang Y; Li Y; Sun E; He Y
    Clin Rheumatol; 2020 Feb; 39(2):425-434. PubMed ID: 31673979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
    Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
    Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.